keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
The ω-3 polyunsaturated fatty acids (PUFAs) found in fish oils provide cardiovascular benefits. Docosahexaenoic acid (DHA), a C22:6 PUFA, is the most abundant ω-3 fatty acid in neural tissues, especially in the retina and brain. It can be synthesized from other dietary ω-3 PUFAs or taken as a nutritional supplement. Docosahexaenoyl glycine consists of DHA with glycine attached at its carboxy terminus.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
5 mg | 約 35 days | ¥ 22,500 |
10 mg | 約 35 days | ¥ 45,000 |
50 mg | 約 35 days | ¥ 181,000 |
100 mg | 約 35 days | ¥ 321,500 |
説明 | The ω-3 polyunsaturated fatty acids (PUFAs) found in fish oils provide cardiovascular benefits. Docosahexaenoic acid (DHA), a C22:6 PUFA, is the most abundant ω-3 fatty acid in neural tissues, especially in the retina and brain. It can be synthesized from other dietary ω-3 PUFAs or taken as a nutritional supplement. Docosahexaenoyl glycine consists of DHA with glycine attached at its carboxy terminus. |
分子量 | 385.54 |
分子式 | C24H35NO3 |
CAS No. | 132850-40-9 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 15 mg/mL
Ethanol: 25 mg/mL
DMF: 20 mg/mL
PBS (pH 7.2): 2 mg/mL
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Docosahexaenoyl Glycine 132850-40-9 Inhibitor inhibitor inhibit